Copyright
©The Author(s) 2000.
World J Gastroenterol. Dec 15, 2000; 6(6): 855-860
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.855
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.855
Table 2 Flow cytometry analysis of cell cycle effects of Ad-RA538 on SGC7901 (%)
| Type of adenovirus | 12 h | 1 d | 2 d | 4 d | 6 d | ||||||||||
| G1 | G2M | S | G1 | G2M | S | G1 | G2M | S | G1 | G2M | S | G1 | G2M | S | |
| Ad-RA538 | 74.6 | 13.0 | 12.4 | 55.7 | 28.2 | 17.2 | 69.9 | 14.0a | 16.1 | 39.7 | 26.6b | 33.8 | 44.4 | 20.9c | 34.7 |
| Ad-LacZ | 66.5 | 15.3 | 18.2 | 59.2 | 18.1 | 22.7 | 59.5 | 22.8 | 17.3 | 71.0 | 12.4 | 16.6 | 73.3 | 8.4 | 18.3 |
- Citation: Chen JP, Lin C, Xu CP, Zhang XY, Wu M. The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo. World J Gastroenterol 2000; 6(6): 855-860
- URL: https://www.wjgnet.com/1007-9327/full/v6/i6/855.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i6.855